Zavation acquires ChoiceSpine
Zavation Medical Products, a spinal implant specialist owned by private equity firm Gemspring Capital, has announced its acquisition of Choice Spine Holdings, a company based in Knoxville known for its extensive array of spinal implant systems. The financial details of the transaction were not disclosed. This acquisition is strategically important for Zavation as it seeks to expand its product portfolio and enhance its distribution channels across both inpatient and outpatient settings.
Choice Spine, founded in 2006, has built a strong reputation in the spinal implant sector with a wide-ranging product lineup covering cervical, thoracolumbar, and interbody systems. The company's commitment to user-focused design and its robust distributor network align well with Zavation's operational model. The acquisition allows Zavation to leverage its vertically integrated manufacturing capabilities to boost innovation and market entry speed, while Choice Spine will retain its brand and operational footprint within the unified organization.
The appointment of Derek Kuyper as Chief Executive Officer comes as part of the acquisition. Previously Zavation's Chief Commercial Officer, Kuyper is set to steer the combined entity’s growth. He emphasizes that Choice Spine’s portfolio and distributor relationships complement Zavation’s existing operations. Similarly, Steve Ainsworth, Co-President of Choice Spine, will remain involved to aid the integration process, underscoring the focus on sustained distributor and customer relations.
For Zavation, the acquisition cements its strategic positioning within the spinal implant market, broadening its competitive footprint. The integration of Choice Spine's offerings allows Zavation to deliver a more comprehensive service to its customers, potentially impacting its competitors who must adjust to this expanded presence. With backing from Gemspring Capital, the merged company aims to execute a long-term strategy focused on innovation-driven growth.
Looking ahead, the key focus will be on the seamless integration of operations and leveraging the synergistic potential of both organizations. As the combined entity moves forward, the industry will watch how Zavation and Choice Spine capitalize on their expanded capabilities and whether the partnership translates into accelerated growth and enhanced market share.
Deal timeline
This transaction is classified in Medical Devices. Figures and status may change as sources update.